Oct 13, 2026, 9:43 AM EDT · 8 days ago NILA Token to Begin Trading on Pionex, Opening Access to Eligible Users Worldwide
Sep 29, 2026, 8:30 AM EDT · 22 days ago MindWave Innovations Expands U.S. Commercial Footprint with Second Agreement to Build and Operate FlashChain for New York-Based Flash Sports & Media
Sep 24, 2026, 8:30 AM EDT · 27 days ago MindWave Innovations Signs Agreement to Build and Operate AQUAEChain, a Platform for Insured ALCI Credits
Aug 3, 2026, 9:00 AM EDT · 2 months ago NILA Token Now Available to Eligible U.S. Users on Webot, a Licensed U.S. Cryptocurrency Exchange
2026-07-30T13:50:28.000Z · 2 months ago Apimeds Pharmaceuticals US Inc trading halted, volatility trading pause
Jul 28, 2026, 8:30 AM EDT · 2 months ago MindWave Innovations Inc., a Wholly Owned Subsidiary of Apimeds Pharmaceuticals US, Inc., Announces MindChain: World's First Fully Insured Blockchain, Launching in October
Jun 8, 2026, 9:00 AM EDT · 4 months ago For Second Straight Year, American Public University System (APUS) Earns Great Place to Work® Certification APEI
May 5, 2026, 2:07 PM EDT · 5 months ago Apimeds Pharmaceuticals US Settles with Inscobee; Merger Proceeds, $100 Million PIPE Financing to Close, and Lōkahi Therapeutics to Advance Apitox Program
2026-03-25T11:21:47.000Z · 7 months ago Inscobee, Apimeds Korea deliver action by written consent to remove directors
2026-03-24T12:35:14.000Z · 7 months ago Apimeds Pharma US reports material breach of merger agreement by Inscobee
Mar 24, 2026, 8:30 AM EDT · 7 months ago Apimeds Pharmaceuticals US Inc. Announces Material Breach of Merger Agreement by Inscobee Inc. (KS:006490) and Apimeds Inc.; Prepares Filing Emergency Action in Delaware Court of Chancery
2026-02-11T21:55:14.000Z · 8 months ago Apimeds Pharmaceuticals confirms FDA Type C meeting for osteoarthritis candidate
Feb 11, 2026, 4:51 PM EST · 8 months ago Apimeds Pharmaceuticals and Lōkahi Therapeutics Announce FDA Type C Meeting Scheduled for LT‑100 (Apitox)
Dec 10, 2025, 9:58 AM EST · 10 months ago Apimeds Pharmaceuticals and MindWave Innovations Announce Closing of $100MM PIPE Financing and Activation of 1,000 Bitcoin to Power AI-Driven Yield Generation Strategy
2025-12-01T14:35:27.000Z · 10 months ago Apimeds Pharmaceuticals, MindWave Innovations announce merger
Dec 1, 2025, 9:25 AM EST · 10 months ago Apimeds and MindWave Announce Merger, Integrating Biotech Growth with AI-Driven Digital Treasury Yield Generation Backed by $100M PIPE
Nov 10, 2025, 10:00 AM EST · 11 months ago Apimeds Brings ai² Futures Lab™ to the Palouse — Partnering with the University of Idaho to Shape the Future of Biotech Innovation
Oct 14, 2025, 3:02 AM EDT · 1 year ago Apimeds Pharmaceuticals says “I love my Ducks” with new ai² Futures Lab™ Program collaboration with the University of Oregon's Lundquist College of Business
Sep 15, 2025, 6:24 PM EDT · 1 year ago Apimeds Expands ai² Future Labs Program to Include University of San Diego Students in Biotech Business Development
2025-09-12T09:20:11.000Z · 1 year ago Apimeds Pharmaceuticals issues statement on FDA draft guidance for pain program
Sep 11, 2025, 9:54 PM EDT · 1 year ago Apimeds Welcomes FDA Draft Guidance as Catalyst for Advancing Apitox Non-Opioid Pain Program
Aug 25, 2025, 2:11 PM EDT · 1 year ago Apimeds Pharmaceuticals US, Inc. Partners with University of Alabama to Advance Biotech Business Development via ai² Future Labs
Jul 15, 2025, 5:34 PM EDT · 1 year ago Apimeds Expands Leadership Team with Dr. Susan Kramer to Lead Product Development and Brian Peters to Lead its ai² Division
May 12, 2025, 5:14 PM EDT · 1 year ago Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering
May 8, 2025, 5:00 PM EDT · 1 year ago Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering
